檢索結果 - Garratt, Chris

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients

    Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients 由 Välitalo, Pyry Antti, Ahtola-Sätilä, Tuula, Wighton, Andrew, Sarapohja, Toni, Pohjanjousi, Pasi, Garratt, Chris

    出版 2013
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  2. 2
    A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU

    A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU 由 Weatherall, Mary, Aantaa, Riku, Conti, Giorgio, Garratt, Chris, Pohjanjousi, Pasi, Lewis, Michael A., Moore, Nicholas, Perez‐Gutthann, Susana

    出版 2017
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  3. 3
    Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients

    Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients 由 Iirola, Timo, Aantaa, Riku, Laitio, Ruut, Kentala, Erkki, Lahtinen, Maria, Wighton, Andrew, Garratt, Chris, Ahtola-Sätilä, Tuula, Olkkola, Klaus T

    出版 2011
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  4. 4
    Effects of dexmedetomidine and propofol on patient-ventilator interaction in difficult-to-wean, mechanically ventilated patients: a prospective, open-label, randomised, multicentre study

    Effects of dexmedetomidine and propofol on patient-ventilator interaction in difficult-to-wean, mechanically ventilated patients: a prospective, open-label, randomised, multicentre... 由 Conti, Giorgio, Ranieri, Vito Marco, Costa, Roberta, Garratt, Chris, Wighton, Andrew, Spinazzola, Giorgia, Urbino, Rosario, Mascia, Luciana, Ferrone, Giuliano, Pohjanjousi, Pasi, Ferreyra, Gabriela, Antonelli, Massimo

    出版 2016
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  5. 5
    Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours

    Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours 由 Bono, Petri, Massard, Christophe, Peltola, Katriina J, Azaro, Analía, Italiano, Antoine, Kristeleit, Rebecca S, Curigliano, Giuseppe, Lassen, Ulrik, Arkenau, Hendrik-Tobias, Hakulinen, Pasi, Garratt, Chris, Ikonen, Tarja, Mustonen, Mika V J, Rodon, Jordi A

    出版 2020
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:

檢索工具: